Chujo, Daisuke
Imagawa, Akihisa
Yasuda, Kazuki
Abiru, Norio
Awata, Takuya
Fukui, Tomoyasu
Ikegami, Hiroshi
Kawasaki, Eiji
Katsuki, Takeshi
Kobayashi, Tetsuro
Kozawa, Junji
Nagasawa, Kan
Ohtsu, Hiroshi
Oikawa, Yoichi
Osawa, Haruhiko
Shimada, Akira
Shimoda, Masayuki
Takahashi, Kazuma
Tsuchiya, Kyoichiro
Tsujimoto, Tetsuro
Yasuda, Hisafumi
Hanafusa, Toshiaki
Kajio, Hiroshi
Funding for this research was provided by:
National Center for Global Health and Medicine (19A1008)
Article History
Received: 12 May 2021
Accepted: 31 August 2021
First Online: 6 September 2021
Declarations
:
: Daisuke Chujo received honorarium for lectures from Eli Lilly and Company; research funding from Novo Nordisk Pharma Ltd., and Sanofi K.K.; Akihisa Imagawa received honorarium for lectures from Astellas Pharma Inc.; clinical commissioned/joint research grant from Astra Zeneca, Soiken Inc., Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Merck KGaA, and Parexel International Inc.; research grant from Shionogi Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company, and Ono Pharmaceutical Co., Ltd.; Norio Abiru received honorarium for lectures from Novo Nordisk Pharma Ltd., Astellas Pharma Inc., and Eli Lilly and Company; research funding from Ono Pharmaceutical Co. Ltd., Bristol Myers Squibb, Taisho Pharmaceutical Co., Ltd., and Astellas Pharma Inc.; Takuya Awata received honorarium for lectures from Astellas Pharma Inc.; Hiroshi Ikegami received honorarium for lectures from Astellas Pharma Inc., Eli Lilly and Company, MSD K.K., Novo Nordisk Pharma Ltd., Novartis Pharma K.K., Sumitomo Dainippon Pharma Co., Ltd., and Terumo Corporation; donations from Abbott Japan Co., Ltd., LifeScan Japan K.K., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., Sumitomo Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company. Akira Shimada received honorarium for lectures from Novo Nordisk Pharma Ltd., Eli Lilly and Company, and Sanofi K.K.; Other authors have no conflict of interest to declare.
: All procedures performed were in accordance with the 1964 Helsinki Declaration and its later amendments and the “ethical guidelines for human genome/gene analysis research” published by the Ministry of Health, Labor, and Welfare of Japan. The study protocol was approved by the ethical committee of the National Center for Global Health and Medicine and other collaborating institutes (ID: NCGM-A-000138-13). Written informed consent was obtained from all participants.